: The Bureau often publishes annual reports or specific legislative documents that may use numbered designations (e.g., "98" referring to the year 1998 or a specific case file).
: A major contract development and manufacturing organization (CDMO) that specializes in biologics. While they manage numerous development programs, "KBI-098" does not appear as a standard public designation for their current internal pipeline or client-facing projects. 2. Criminal Justice and Public Safety
"KBI" is the standard abbreviation for the . KBI-098
The identifier appears to be a combination of terms that relate to several distinct professional and scientific fields. To help clarify which "KBI-098" you are referring to, below is an analysis of how these components are typically used in specialized sectors: 1. Pharmacology and Drug Development
: A prominent small molecule being developed by BioVersys in collaboration with GSK to treat tuberculosis. It is designed to overcome antibiotic resistance and is currently in Phase 2 clinical trials. : The Bureau often publishes annual reports or
In the pharmaceutical industry, alphanumeric codes are used to identify investigational drug candidates.
There is no definitive widely recognized entity, chemical compound, or project known as . To help clarify which "KBI-098" you are referring
: Geological and forensic studies from 1998 sometimes use similar numbering for "Open File Reports" in the state of Kansas. Drug Research Formulation Lab - KBI Biopharma